Fucoidan has also been found to reduce NPC1L1 expression, inhibit cholesterol uptake in the intestine, and prevent hyperlipidemia-induced atherosclerosis in apoE−/− mice [25]. This evidence concerns the gene APOE and hyperlipidemia.